Search research articles
Contact Us
Filters
Showing results (51-60 of 205) with videos related to
Page
of 21
Sort By:
Oncogene
|
February 1, 1991
Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products
D H Yan, L S Chang, M C Hung
The Journal of Biological Chemistry
|
May 5, 1993
Effects of truncation of human pro-tumor necrosis factor transmembrane domain on cellular targeting
T Utsumi, A Levitan, M C Hung, et al.
Oncogene
|
August 1, 1989
Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract
X Zhang, E Silva, D Gershenson, et al.
Cancer Research
|
December 1, 1993
Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A
D Yu, D Shi, M Scanlon, et al.
Human Gene Therapy
|
August 28, 1998
A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer
G N Hortobagyi, M C Hung, G Lopez-Berestein
Advances in Experimental Medicine and Biology
|
May 16, 2000
Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer
M C Hung, G N Hortobagyi, N T Ueno
Chemical & Pharmaceutical Bulletin
|
September 19, 2000
Taxane diterpenoids from seeds of Taxus mairei
Y C Shen, C Y Chen, M C Hung
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu
R L Hong, W H Spohn, M C Hung
Seminars in Oncology
|
September 11, 1999
Recent developments in breast cancer therapy
G N Hortobagyi, M C Hung, A U Buzdar
Oncogene
|
May 18, 1995
HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model
Y Zhang, D Yu, W Xia, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 205) with videos related to
Sort By:
Page
of 21
Oncogene
|
February 1, 1991
Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products
D H Yan, L S Chang, M C Hung
The Journal of Biological Chemistry
|
May 5, 1993
Effects of truncation of human pro-tumor necrosis factor transmembrane domain on cellular targeting
T Utsumi, A Levitan, M C Hung, et al.
Oncogene
|
August 1, 1989
Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract
X Zhang, E Silva, D Gershenson, et al.
Cancer Research
|
December 1, 1993
Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A
D Yu, D Shi, M Scanlon, et al.
Human Gene Therapy
|
August 28, 1998
A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer
G N Hortobagyi, M C Hung, G Lopez-Berestein
Advances in Experimental Medicine and Biology
|
May 16, 2000
Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer
M C Hung, G N Hortobagyi, N T Ueno
Chemical & Pharmaceutical Bulletin
|
September 19, 2000
Taxane diterpenoids from seeds of Taxus mairei
Y C Shen, C Y Chen, M C Hung
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu
R L Hong, W H Spohn, M C Hung
Seminars in Oncology
|
September 11, 1999
Recent developments in breast cancer therapy
G N Hortobagyi, M C Hung, A U Buzdar
Oncogene
|
May 18, 1995
HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model
Y Zhang, D Yu, W Xia, et al.
Page
of 21